Federated Hermes’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.99K Buy
620
+227
+58% +$2.63K ﹤0.01% 1853
2025
Q4
$3.78K Hold
393
﹤0.01% 1916
2025
Q3
$3.69K Buy
+393
New +$3.75K ﹤0.01% 1971
2024
Q4
Sell
-114
Closed -$2.82K 2074
2024
Q3
$2.82K Buy
114
+60
+111% +$1.56K ﹤0.01% 1917
2024
Q2
$1.37K Buy
+54
New +$1.4K ﹤0.01% 1933
2021
Q1
Sell
-9,175
Closed -$415K 2217
2020
Q4
$415K Sell
9,175
-71,336
-89% -$2.71M ﹤0.01% 1561
2020
Q3
$2.85M Buy
80,511
+337
+0.4% +$12.2K 0.01% 880
2020
Q2
$3.02M Buy
80,174
+80,138
+222,606% +$2.64M 0.01% 849
2020
Q1
$1K Buy
+36
New +$1.46K ﹤0.01% 2072
2019
Q4
Sell
-158
Closed -$9K 2207
2019
Q3
$9K Buy
+158
New +$8.11K ﹤0.01% 1891
2018
Q1
Sell
-2,832
Closed -$153K 2153
2017
Q4
$153K Sell
2,832
-2,250
-44% -$125K ﹤0.01% 1551
2017
Q3
$295K Sell
5,082
-4,294
-46% -$224K ﹤0.01% 1446
2017
Q2
$463K Buy
9,376
+363
+4% +$16.7K ﹤0.01% 1394
2017
Q1
$392K Sell
9,013
-9,444
-51% -$451K ﹤0.01% 1390
2016
Q4
$904K Sell
18,457
-14,572
-44% -$674K ﹤0.01% 1168
2016
Q3
$1.58M Buy
33,029
+9,543
+41% +$471K ﹤0.01% 947
2016
Q2
$1.26M Sell
23,486
-2,069
-8% -$97.5K ﹤0.01% 1023
2016
Q1
$1.14M Buy
25,555
+25,551
+638,775% +$1.04M ﹤0.01% 1042
2015
Q4
$1K Hold
4
﹤0.01% 1989
2015
Q3
$1K Buy
+4
New +$139 ﹤0.01% 1888
2015
Q2
Sell
-13,629
Closed -$561K 1948
2015
Q1
$561K Buy
13,629
+451
+3% +$18.2K ﹤0.01% 1334
2014
Q4
$537K Sell
13,178
-1,006
-7% -$39.3K ﹤0.01% 1332
2014
Q3
$520K Sell
14,184
-2,958
-17% -$128K ﹤0.01% 1344
2014
Q2
$794K Buy
17,142
+3,979
+30% +$177K ﹤0.01% 1232
2014
Q1
$541K Buy
13,163
+8,586
+188% +$319K ﹤0.01% 1327
2013
Q4
$175K Buy
4,577
+1,197
+35% +$36.9K ﹤0.01% 1503
2013
Q3
$81K Buy
3,380
+1,183
+54% +$26.6K ﹤0.01% 1586
2013
Q2
$37K Buy
+2,197
New +$31.7K ﹤0.01% 1622

Other funds holding ANIK